Tech Company Financing Transactions
Traxion Therapeutics Funding Round
On 3/31/2008, Traxion Therapeutics secured $74 thousand in funding from TEDCO.
Transaction Overview
Company Name
Announced On
3/31/2008
Transaction Type
Venture Equity
Amount
$74,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
1303 South Potomac St
Baltimore, MD 21224
USA
Baltimore, MD 21224
USA
Phone
Undisclosed
Website
Email Address
Overview
Traxion Therapeutics Inc. is a biotech company focused on the development of novel drugs for the treatment of intractable pain, specifically neuropathic pain.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kerrie Brady
Browse more venture capital transactions:
Prev: 3/31/2008: Acclaris venture capital transaction
Next: 3/31/2008: Netuitive venture capital transaction
Share this article
About Our VC Transactions Data
We report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs